Presentation is loading. Please wait.

Presentation is loading. Please wait.

Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer?  Anna Lee, MD, MPH, Andrew T.

Similar presentations


Presentation on theme: "Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer?  Anna Lee, MD, MPH, Andrew T."— Presentation transcript:

1 Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer?  Anna Lee, MD, MPH, Andrew T. Wong, MD, David Schwartz, MD, Joseph P. Weiner, MD, Virginia W. Osborn, MD, David Schreiber, MD  The Annals of Thoracic Surgery  Volume 102, Issue 2, Pages (August 2016) DOI: /j.athoracsur Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Kaplan-Meier survival estimates were derived for patients with pathologic complete response (pCR) and residual disease after esophagectomy. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions


Download ppt "Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer?  Anna Lee, MD, MPH, Andrew T."

Similar presentations


Ads by Google